BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 18508885)

  • 1. Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses.
    Rojek JM; Sanchez AB; Nguyen NT; de la Torre JC; Kunz S
    J Virol; 2008 Aug; 82(15):7677-87. PubMed ID: 18508885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Old world arenaviruses enter the host cell via the multivesicular body and depend on the endosomal sorting complex required for transport.
    Pasqual G; Rojek JM; Masin M; Chatton JY; Kunz S
    PLoS Pathog; 2011 Sep; 7(9):e1002232. PubMed ID: 21931550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lassa Virus Cell Entry via Dystroglycan Involves an Unusual Pathway of Macropinocytosis.
    Oppliger J; Torriani G; Herrador A; Kunz S
    J Virol; 2016 Jul; 90(14):6412-6429. PubMed ID: 27147735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of DC-SIGN in Lassa virus entry into human dendritic cells.
    Goncalves AR; Moraz ML; Pasquato A; Helenius A; Lozach PY; Kunz S
    J Virol; 2013 Nov; 87(21):11504-15. PubMed ID: 23966408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor binding and cell entry of Old World arenaviruses reveal novel aspects of virus-host interaction.
    Kunz S
    Virology; 2009 May; 387(2):245-9. PubMed ID: 19324387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell entry by human pathogenic arenaviruses.
    Rojek JM; Kunz S
    Cell Microbiol; 2008 Apr; 10(4):828-35. PubMed ID: 18182084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multivalent vaccination strategy for the prevention of Old World arenavirus infection in humans.
    Botten J; Whitton JL; Barrowman P; Sidney J; Whitmire JK; Alexander J; Kotturi MF; Sette A; Buchmeier MJ
    J Virol; 2010 Oct; 84(19):9947-56. PubMed ID: 20668086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly Pathogenic New World Arenavirus Infection Activates the Pattern Recognition Receptor Protein Kinase R without Attenuating Virus Replication in Human Cells.
    Huang C; Kolokoltsova OA; Mateer EJ; Koma T; Paessler S
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular entry of lymphocytic choriomeningitis virus.
    Rojek JM; Perez M; Kunz S
    J Virol; 2008 Feb; 82(3):1505-17. PubMed ID: 18045945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axl Can Serve as Entry Factor for Lassa Virus Depending on the Functional Glycosylation of Dystroglycan.
    Fedeli C; Torriani G; Galan-Navarro C; Moraz ML; Moreno H; Gerold G; Kunz S
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of recombinant lymphocytic choriomeningitis virus/Lassa virus in vivo highlights the importance of the GPC cytosolic tail in viral fitness.
    Sommerstein R; Ramos da Palma J; Olschläger S; Bergthaler A; Barba L; Lee BP; Pasquato A; Flatz L
    J Virol; 2014 Aug; 88(15):8340-8. PubMed ID: 24829355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor.
    Takenaga T; Zhang Z; Muramoto Y; Fehling SK; Hirabayashi A; Takamatsu Y; Kajikawa J; Miyamoto S; Nakano M; Urata S; Groseth A; Strecker T; Noda T
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly Pathogenic New World and Old World Human Arenaviruses Induce Distinct Interferon Responses in Human Cells.
    Huang C; Kolokoltsova OA; Yun NE; Seregin AV; Ronca S; Koma T; Paessler S
    J Virol; 2015 Jul; 89(14):7079-88. PubMed ID: 25926656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamp1 Increases the Efficiency of Lassa Virus Infection by Promoting Fusion in Less Acidic Endosomal Compartments.
    Hulseberg CE; Fénéant L; Szymańska KM; White JM
    mBio; 2018 Jan; 9(1):. PubMed ID: 29295909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
    Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Interactome Analysis Reveals that STT3B Is Required for N-Glycosylation of Lassa Virus Glycoprotein.
    Zhu S; Wan W; Zhang Y; Shang W; Pan X; Zhang LK; Xiao G
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An mRNA-LNP-based Lassa virus vaccine induces protective immunity in mice.
    Hashizume M; Takashima A; Iwasaki M
    J Virol; 2024 Jun; 98(6):e0057824. PubMed ID: 38767352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lassa Virus, but Not Highly Pathogenic New World Arenaviruses, Restricts Immunostimulatory Double-Stranded RNA Accumulation during Infection.
    Mateer EJ; Maruyama J; Card GE; Paessler S; Huang C
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32051278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses.
    Rodrigo WW; de la Torre JC; Martínez-Sobrido L
    J Virol; 2011 Feb; 85(4):1684-95. PubMed ID: 21123370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residues K465 and G467 within the Cytoplasmic Domain of GP2 Play a Critical Role in the Persistence of Lymphocytic Choriomeningitis Virus in Mice.
    Iwasaki M; Ng CT; Cubitt B; de la Torre JC
    J Virol; 2016 Nov; 90(22):10102-10112. PubMed ID: 27581982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.